These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14535873)

  • 21. Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin.
    Gisbert JP; Pérez-Aisa A; Castro-Fernández M; Barrio J; Rodrigo L; Cosme A; Gisbert JL; Marcos S; Moreno-Otero R
    Dig Liver Dis; 2010 Apr; 42(4):287-90. PubMed ID: 19632166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
    Lerang F; Moum B; Haug JB; Tolås P; Breder O; Aubert E; Høie O; Søberg T; Flaaten B; Farup P; Berge T
    Am J Gastroenterol; 1997 Feb; 92(2):248-53. PubMed ID: 9040200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
    Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
    Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is a long-term ranitidine-based triple therapy against Helicobacter pylori only a heritage of the past? A prospective, randomized clinicopharmacological study.
    Pellegrini M; Urso R; Giorgi G; Bayeli PF; Marzocca G; Cerretani D
    Aliment Pharmacol Ther; 2005 Aug; 22(4):343-8. PubMed ID: 16098001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection.
    Huang WH; Ho AS; Shyu RY; Lee SC; Lee MM; Hsu CT
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Aug; 61(8):448-55. PubMed ID: 9745160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism.
    Sheu BS; Kao AW; Cheng HC; Hunag SF; Chen TW; Lu CC; Wu JJ
    Aliment Pharmacol Ther; 2005 Feb; 21(3):283-8. PubMed ID: 15691303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
    Huang AH; Sheu BS; Yang HB; Huang CC; Wu JJ; Lin XZ
    J Formos Med Assoc; 2000 Sep; 99(9):704-9. PubMed ID: 11000734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bismuth improves efficacy of proton-pump inhibitor clarithromycin, metronidazole triple Helicobacter pylori therapy despite a high prevalence of antimicrobial resistance.
    Long X; Chen Q; Yu L; Liang X; Liu W; Lu H
    Helicobacter; 2018 Jun; 23(3):e12485. PubMed ID: 29696736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori.
    Moayyedi P; Sahay P; Tompkins DS; Axon AT
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):835-40. PubMed ID: 8574714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates.
    Sánchez-Delgado J; García-Iglesias P; Castro-Fernández M; Bory F; Barenys M; Bujanda L; Lisozain J; Calvo MM; Torra S; Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2012 Jul; 36(2):190-6. PubMed ID: 22591220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy and safety of one-week triple therapy with lansoprazole, clarithromycin, and metronidazole for the treatment of Helicobacter pylori infection in Japanese patients.
    Takimoto T; Satoh K; Taniguchi Y; Saifuku K; Kihira K; Seki M; Yoshida Y; Ido K; Kimura K
    Helicobacter; 1997 Jun; 2(2):86-91. PubMed ID: 9432334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
    Grimley CE; Penny A; O'sullivan M; Shebani M; Lismore JR; Cross R; Illing RC; Loft DE; Nwokolo CU
    Aliment Pharmacol Ther; 1999 Jul; 13(7):869-73. PubMed ID: 10383520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
    Francavilla R; Lionetti E; Castellaneta SP; Magistà AM; Boscarelli G; Piscitelli D; Amoruso A; Di Leo A; Miniello VL; Francavilla A; Cavallo L; Ierardi E
    Gastroenterology; 2005 Nov; 129(5):1414-9. PubMed ID: 16285942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study.
    Katelaris PH; Adamthwaite D; Midolo P; Yeomans ND; Davidson G; Lambert J
    Aliment Pharmacol Ther; 2000 Jun; 14(6):751-8. PubMed ID: 10848659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: a short report.
    Schwartz H; Krause R; Siepman N; Haber M; Weissfeld A; Kidd S; Rose P; Sahba B
    Helicobacter; 1996 Dec; 1(4):251-5. PubMed ID: 9398876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies.
    Wong WM; Wong BC; Lu H; Gu Q; Yin Y; Wang WH; Fung FM; Lai KC; Xia HH; Xiao SD; Lam SK
    Aliment Pharmacol Ther; 2002 Apr; 16(4):793-8. PubMed ID: 11929398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
    Yurenev GL; Partzvania-Vinogradova EV; Andreev DN; Dicheva DT; Maiev IV
    Ter Arkh; 2018 Aug; 90(8):33-39. PubMed ID: 30701937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents.
    Moshkowitz M; Reif S; Brill S; Ringel Y; Arber N; Halpern Z; Bujanover Y
    Pediatrics; 1998 Jul; 102(1):e14. PubMed ID: 9651466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
    Wong BC; Xiao SD; Hu FL; Qian SC; Huang NX; Li YY; Hu PJ; Daldiyono ; Manan C; Lesmana L; Carpio RE; Perez JY; Fock KM; Kachintorn U; Phornphutkul K; Kullavanijaya P; Ho J; Lam SK
    Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients.
    Goh K; Parasakthi N; Cheah P; Ranjeev C; Rosmawati M; Tan Y; Chin S
    J Gastroenterol Hepatol; 2000 Aug; 15(8):910-4. PubMed ID: 11022833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.